Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection

Malaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Adriana Temporão, Margarida Sanches-Vaz, Rafael Luís, Helena Nunes-Cabaço, Terry K. Smith, Miguel Prudêncio, Luisa M. Figueiredo
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/5eaf28c1c3664433b188f94e8f25947e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5eaf28c1c3664433b188f94e8f25947e
record_format dspace
spelling oai:doaj.org-article:5eaf28c1c3664433b188f94e8f25947e2021-11-18T09:12:18ZExcreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection1935-27271935-2735https://doaj.org/article/5eaf28c1c3664433b188f94e8f25947e2021-10-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580256/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735Malaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. berghei liver infection and decreases malaria severity in mice. However, whether this effect requires an active trypanosome infection remained unknown. Here, we show that Plasmodium liver infection can also be inhibited by the serum of a mouse previously infected by T. brucei and by total protein lysates of this kinetoplastid. Biochemical characterisation showed that the anti-Plasmodium activity of the total T. brucei lysates depends on its protein fraction, but is independent of the abundant variant surface glycoprotein. Finally, we found that the protein(s) responsible for the inhibition of Plasmodium infection is/are present within a fraction of ~350 proteins that are excreted to the bloodstream of the host. We conclude that the defence mechanism developed by trypanosomes against Plasmodium relies on protein excretion. This study opens the door to the identification of novel antiplasmodial intervention strategies. Author summary Malaria and sleeping sickness are parasitic illnesses that overlap geographically, making it likely that co-infections between the two causative parasites occur. It was previously shown that when mice are first infected with Trypanosoma brucei, there was an attenuation of the subsequent infection by Plasmodium. Here we sought to assess whether an active T. brucei infection was required for this impairment, and to unravel the mechanism behind this phenomenon. We found that not only T. brucei total lysates are able to inhibit Plasmodium liver infection, but also that mice that received these lysates are partly protected from developing severe malaria pathology. We further showed that this protective effect is mediated by proteins excreted by trypanosomes. Our study paves the way to the development of novel antiplasmodial intervention strategies, based on the mechanism involved during the co-infection between T. brucei and Plasmodium.Adriana TemporãoMargarida Sanches-VazRafael LuísHelena Nunes-CabaçoTerry K. SmithMiguel PrudêncioLuisa M. FigueiredoPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 15, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
spellingShingle Arctic medicine. Tropical medicine
RC955-962
Public aspects of medicine
RA1-1270
Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
description Malaria, a disease caused by Plasmodium parasites, remains a major threat to public health globally. It is the most common disease in patients with sleeping sickness, another parasitic illness, caused by Trypanosoma brucei. We have previously shown that a T. brucei infection impairs a secondary P. berghei liver infection and decreases malaria severity in mice. However, whether this effect requires an active trypanosome infection remained unknown. Here, we show that Plasmodium liver infection can also be inhibited by the serum of a mouse previously infected by T. brucei and by total protein lysates of this kinetoplastid. Biochemical characterisation showed that the anti-Plasmodium activity of the total T. brucei lysates depends on its protein fraction, but is independent of the abundant variant surface glycoprotein. Finally, we found that the protein(s) responsible for the inhibition of Plasmodium infection is/are present within a fraction of ~350 proteins that are excreted to the bloodstream of the host. We conclude that the defence mechanism developed by trypanosomes against Plasmodium relies on protein excretion. This study opens the door to the identification of novel antiplasmodial intervention strategies. Author summary Malaria and sleeping sickness are parasitic illnesses that overlap geographically, making it likely that co-infections between the two causative parasites occur. It was previously shown that when mice are first infected with Trypanosoma brucei, there was an attenuation of the subsequent infection by Plasmodium. Here we sought to assess whether an active T. brucei infection was required for this impairment, and to unravel the mechanism behind this phenomenon. We found that not only T. brucei total lysates are able to inhibit Plasmodium liver infection, but also that mice that received these lysates are partly protected from developing severe malaria pathology. We further showed that this protective effect is mediated by proteins excreted by trypanosomes. Our study paves the way to the development of novel antiplasmodial intervention strategies, based on the mechanism involved during the co-infection between T. brucei and Plasmodium.
format article
author Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
author_facet Adriana Temporão
Margarida Sanches-Vaz
Rafael Luís
Helena Nunes-Cabaço
Terry K. Smith
Miguel Prudêncio
Luisa M. Figueiredo
author_sort Adriana Temporão
title Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_short Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_full Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_fullStr Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_full_unstemmed Excreted Trypanosoma brucei proteins inhibit Plasmodium hepatic infection
title_sort excreted trypanosoma brucei proteins inhibit plasmodium hepatic infection
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/5eaf28c1c3664433b188f94e8f25947e
work_keys_str_mv AT adrianatemporao excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT margaridasanchesvaz excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT rafaelluis excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT helenanunescabaco excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT terryksmith excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT miguelprudencio excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
AT luisamfigueiredo excretedtrypanosomabruceiproteinsinhibitplasmodiumhepaticinfection
_version_ 1718420966887915520